Mylan, AMD bankruptcy candidates?
Mylan: In a classic case of management empire building, Mylan overpaid big time when it bought Merck’s generic business back in 2007 and is now stuck with $5 billion of long-term debt as a result.
AMD: When will AMD actually make money again? The question is becoming more important by the day since it carries over $5 billion in long-term debt.
See IPBiz posts, including
http://ipbiz.blogspot.com/2006/11/microunity-goes-after-amd-for-patent.html
http://ipbiz.blogspot.com/2009/04/roche-sues-mylan-in-hatch-waxman-case.html
http://ipbiz.blogspot.com/2008/06/daiichi-sankyo-sues-mylan-over-azor.html
0 Comments:
Post a Comment
<< Home